report.object
AI agents for payers and health insurance operations
Expert-reviewed from public records, platform data, primary sources, and private research beyond AI search. Use /api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/sample before purchase, then download PDF, JSON, or Markdown after checkout.
page.markdown
AI agents for payers and health insurance operations.md
# AI agents for payers and health insurance operations
Health-insurance agents should be measured by net member impact: benefit answers, authorizations, claims edits, fraud holds, outreach, grievances and appeals tied to reversals, delayed care and complaints.
## Object
| field | value |
| ---------------- | ---------------------------------------- |
| report_id | RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS |
| schema_version | 2026-05-28 |
| last_updated_at | 2026-06-02 |
| category | AGENTS |
| sector | Healthcare delivery |
| region | USA |
| confidence_score | 0.87 |
| source_count | 28 |
| evidence_count | 28 |
## Endpoints
| action | endpoint |
| ------------ | ------------------------------------------------------------------- |
| summary | /api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS |
| sample | /api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/sample |
| schema | /api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/schema |
| quote | /api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/quote |
| purchase | /checkout/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS?view=agent |
| versions | /api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/versions |
| changelog | /api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/changelog |
| monitor | /api/v1/monitors?report_id=RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS |
| mcp_resource | colophon://reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/sample |
## Coverage
| field | value |
| -------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| category | AGENTS |
| sector | Healthcare delivery |
| region | USA |
| topics | payer AI, health insurance operations, claims, utilization management, care management, fraud waste and abuse, member service, prior authorization, Medicare Advantage, appeals |
| source_classes | regulation, implementation_guide, proposed_rule, state_guidance, accreditation, programme_manual, insurance_governance, agency_faq, independent_policy_analysis, federal_oversight_report, operating_rule_benchmark, administrative_transaction_benchmark, federal_regulation, vendor_directory |
| update_cadence | Weekly |
## Sample JSON
```json
{
"report_id": "RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS",
"slug": "ai-agents-payers-health-insurance-operations",
"schema_version": "2026-05-28",
"title": "AI agents for payers and health insurance operations",
"abstract": "Health-insurance agents should be measured by net member impact: benefit answers, authorizations, claims edits, fraud holds, outreach, grievances and appeals tied to reversals, delayed care and complaints.",
"category": "AGENTS",
"sector": "Healthcare delivery",
"region": "USA",
"topics": [
"payer AI",
"health insurance operations",
"claims",
"utilization management",
"care management",
"fraud waste and abuse",
"member service",
"prior authorization",
"Medicare Advantage",
"appeals"
],
"last_updated_at": "2026-06-02T00:00:00Z",
"source_count": 28,
"evidence_count": 28,
"confidence_score": 0.87,
"web_url": "/r/ai-agents-payers-health-insurance-operations/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS",
"sample_endpoint": "/api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/sample",
"inventory_endpoint": "/api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/inventory",
"full_endpoint": "/api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/full",
"schema_endpoint": "/api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_AGENTS_PAYERS/schema",
"redaction": {
"status": "sample",
"paid_sections_redacted": true,
"preview_limits": [
"summary",
"table_of_contents",
"evidence_profile"
]
},
"coverage": {
"category": "AGENTS",
"sector": "Healthcare delivery",
"region": "USA",
"topics": [
"payer AI",
"health insurance operations",
"claims",
"utilization management",
"care management",
"fraud waste and abuse",
"member service",
"prior authorization",
"Medicare Advantage",
"appeals"
],
"source_classes": [
"regulation",
"implementation_guide",
"proposed_rule",
"state_guidance",
"accreditation",
"programme_manual",
"insurance_governance",
"agency_faq",
"independent_policy_analysis",
"federal_oversight_report",
"operating_rule_benchmark",
"administrative_transaction_benchmark",
"federal_regulation",
"vendor_directory"
]
},
"confidence": {
"overall_confidence": 0.87,
"source_quality": 0.89,
"source_recency": 0.89,
"source_density": 0.86,
"claim_verifiability": 0.87,
"geographic_coverage": 0.74,
"known_gaps": [
"Public evidence is strongest for U.S. payer regulation and weaker for commercial-plan operating telemetry.",
"Medicare Advantage and administrative-transaction evidence supplies public denominators, but commercial-plan appeal, grievance and provider-abrasion telemetry remains private.",
"Fraud models are hard to compare publicly because labels, investigations and recoveries are confidential."
]
},
"document": {
"object": "report_document",
"schemaVersion": "2026-05-28",
"title": "AI agents for payers and health insurance operations",
"subtitle": "The hidden denominator is adverse member impact, not handled work.",
"abstract": "Health-insurance agents should be measured by net member impact: benefit answers, authorizations, claims edits, fraud holds, outreach, grievances and appeals tied to reversals, delayed care and complaints.",
"category": "AGENTS",
"sector": "Healthcare delivery",
"region": "USA",
"topics": [
"payer AI",
"health insurance operations",
"claims",
"utilization management",
"care management",
"fraud waste and abuse",
"member service",
"prior authorization",
"Medicare Advantage",
"appeals"
],
"sources": [
{
"id": "S1",
"label": "CMS - Interoperability and Prior Authorization Final Rule CMS-0057-F",
"publisher": "CMS",
"sourceClass": "regulation",
"accessedAt": "2026-06-02",
"status": "verified",
"access": "sample",
"originalUrl": "https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f",
"transformChain": [],
"url": "https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f"
},
{
"id": "S2",
"label": "HL7 Da Vinci - Prior Authorization Support FHIR IG",
"publisher": "HL7",
"sourceClass": "implementation_guide",
"accessedAt": "2026-06-02",
"status": "verified",
"access": "sample",
"originalUrl": "https://hl7.org/fhir/us/davinci-pas/STU2/",
"transformChain": [],
"url": "https://hl7.org/fhir/us/davinci-pas/STU2/"
},
{
"id": "S3",
"label": "CMS - 2026 Interoperability Standards and Prior Authorization for Drugs Proposed Rule",
"publisher": "CMS",
"sourceClass": "proposed_rule",
"accessedAt": "2026-06-02",
"status": "verified",
"access": "sample",
"originalUrl": "https://www.cms.gov/newsroom/fact-sheets/2026-cms-interoperability-standards-prior-authorization-drugs-proposed-rule",
"transformChain": [],
"provenanceNotes": "Use as workflow or timing evidence; verify final status and local applicability before relying on exact obligations.",
"url": "https://www.cms.gov/newsroom/fact-sheets/2026-cms-interoperability-standards-prior-authorization-drugs-proposed-rule"
},
{
"id": "S4",
"label": "CMS - 2024 Medicare Advantage and Part D Final Rule",
"publisher": "CMS",
"sourceClass": "regulation",
"accessedAt": "2026-06-02",
"status": "verified",
"access": "sample",
"originalUrl": "https://www.cms.gov/newsroom/fact-sheets/2024-medicare-advantage-and-part-d-final-rule-cms-4201-f",
"transformChain": [],
"url": "https://www.cms.gov/newsroom/fact-sheets/2024-medicare-advantage-and-part-d-final-rule-cms-4201-f"
},
{
"id": "S11",
"label": "CMS - CMS-4201-F coverage criteria and utilization-management FAQ",
"publisher": "CMS",
"sourceClass": "agency_faq",
"accessedAt": "2026-06-02",
"status": "verified",
"access": "sample",
"originalUrl": "https://www.cms.gov/files/document/hpms-memo-faq-coverage-criteria-and-utilization-management-cms-4201-f-02-6-2024-pdf.pdf",
"publicationDate": "2024-02-06",
"transformChain": [],
"url": "https://www.cms.gov/files/document/hpms-memo-faq-coverage-criteria-and-utilization-management-cms-4201-f-02-6-2024-pdf.pdf"
},
{
"id": "S12",
"label": "KFF - Medicare Advantage prior authorization determinations in 2024",
"publisher": "KFF",
"sourceClass": "independent_policy_analysis",
"accessedAt": "2026-06-02",
"status": "verified",
"access": "sample",
"originalUrl": "https://www.kff.org/medicare/medicare-advantage-insurers-made-nearly-53-million-prior-authorization-determinations-in-2024/",
"publicationDate": "2026-01-28",
"transformChain": [],
"url": "https://www.kff.org/medicare/medicare-advantage-insurers-made-nearly-53-million-prior-authorization-determinations-in-2024/"
},
{
"id": "S13",
"label": "HHS OIG - Medicare Advantage prior authorization denials",
"publisher": "HHS Office of Inspector General",
"sourceClass": "federal_oversight_report",
"accessedAt": "2026-06-02",
"status": "verified",
"access": "sample",
"originalUrl": "https://oig.hhs.gov/reports/all/2022/some-medicare-advantage-organization-denials-of-prior-authorization-requests-raise-concerns-about-beneficiary-access-to-medically-necessary-care/",
"publicationDate": "2022-04-01",
"transformChain": [],
"url": "https://oig.hhs.gov/reports/all/2022/some-medicare-advantage-organization-denials-of-prior-authorization-requests-raise-concerns-about-beneficiary-access-to-medically-necessary-care/"
},
{
"id": "S14",
"label": "CAQH CORE - prior authorization priority topics",
"publisher": "CAQH CORE",
"sourceClass": "operating_rule_benchmark",
"accessedAt": "2026-06-02",
"status": "verified",
"access": "sample",
"originalUrl": "https://www.caqh.org/core/priority-topics",
"transformChain": [],
"url": "https://www.caqh.org/core/priority-topics"
},
{
"id": "S15",
"label": "CAQH - 2024 Index key takeaways",
"publisher": "CAQH",
"sourceClass": "administrative_transaction_benchmark",
"accessedAt": "2026-06-02",
"status": "verified",
"access": "sample",
"originalUrl": "https://www.caqh.org/hubfs/Index/2024%20Index%20Report/CAQH%202024%20Index%20Report%20Key%20Takeaways%20FINAL.pdf",
"transformChain": [],
"url": "https://www.caqh.org/hubfs/Index/2024%20Index%20Report/CAQH%202024%20Index%20Report%20Key%20Takeaways%20FINAL.pdf"
}
],
"evidence": [
{
"id": "E1",
"sourceId": "S1",
"claimIds": [
"C1",
"C2"
],
"summary": "CMS-0057-F requires impacted payers to implement FHIR APIs for patient, provider, payer-to-payer and prior-authorization data exchange, with public prior-authorization metrics beginning in 2026 and key API requirements generally due by 1 January 2027.",
"status": "verified",
"confidence": 0.9,
"access": "sample"
},
{
"id": "E2",
"sourceId": "S2",
"claimIds": [
"C1",
"C2"
],
"summary": "Da Vinci PAS defines prior-authorization request, response and status workflows relevant to payer operating-agent routes.",
"status": "verified",
"confidence": 0.86,
"access": "sample"
},
{
"id": "E3",
"sourceId": "S3",
"claimIds": [
"C2"
],
"summary": "CMS's drug prior-authorization proposal would extend electronic authorization expectations into pharmacy-benefit workflows, with the public comment period closing on 15 June 2026.",
"status": "monitor",
"confidence": 0.84,
"access": "sample"
},
{
"id": "E4",
"sourceId": "S4",
"claimIds": [],
"summary": "CMS requires MA plans to maintain utilization-management committees reviewing policies against Traditional Medicare coverage rules.",
"status": "verified",
"confidence": 0.86,
"access": "sample"
},
{
"id": "E11",
"sourceId": "S11",
"claimIds": [],
"summary": "CMS's CMS-4201-F FAQ says algorithms or software tools may assist MA coverage determinations, but the MA organization remains responsible for compliance and medical-necessity decisions must consider individual circumstances, physician recommendations and clinical notes.",
"status": "verified",
"confidence": 0.9,
"access": "sample"
},
{
"id": "E12",
"sourceId": "S12",
"claimIds": [],
"summary": "KFF reports that Medicare Advantage insurers made 52.8 million prior-authorization determinations in 2024, denied 4.1 million requests, had an overall 7.7% denial rate, saw 11.5% of denials appealed, and overturned 80.7% of appealed denials.",
"status": "verified",
"confidence": 0.91,
"access": "sample"
},
{
"id": "E13",
"sourceId": "S13",
"claimIds": [],
"summary": "HHS OIG found that 13% of prior-authorization denials in its Medicare Advantage sample met Medicare coverage rules, supporting independent sampling of AI-assisted adverse coverage decisions.",
"status": "verified",
"confidence": 0.9,
"access": "sample"
},
{
"id": "E14",
"sourceId": "S14",
"claimIds": [
"C1",
"C2"
],
"summary": "CAQH CORE says only 35% of medical-industry prior authorizations are conducted fully electronically using the X12 278 transaction and identifies transaction, operating-rule, documentation, vendor-readiness, portal and state-law barriers.",
"status": "verified",
"confidence": 0.87,
"access": "sample"
},
{
"id": "E15",
"sourceId": "S15",
"claimIds": [],
"summary": "CAQH 2024 Index key takeaways estimate $515 million in annual industry savings and 14 minutes saved per authorization from adopting the electronic standard.",
"status": "verified",
"confidence": 0.85,
"access": "sample"
}
],
"claims": [
{
"id": "C1",
"statement": "Payer AI agents are procurement-relevant now because prior authorization and interoperability have become implementation, public-metric and compliance routes.",
"confidence": 0.86,
"evidenceIds": [
"E1",
"E2",
"E14"
],
"access": "sample"
},
{
"id": "C2",
"statement": "Prior-authorization agents need payer-specific route approval across coverage discovery, documentation, submission, status, medical, pharmacy, provider, member and appeal workflows.",
"confidence": 0.85,
"evidenceIds": [
"E1",
"E2",
"E3"
],
"access": "sample"
}
],
"colophon": {
"checkedAt": "2026-06-02",
"latestRevisionAt": "2026-06-02T00:00:00Z",
"reviewStandard": "expert_human_reviewed",
"kinetics": {
"speed": "moderate",
"impact": 0.92,
"momentum": 0.81,
"businessImpact": "Payer AI depends on net member impact, because administrative savings can reappear as denials, appeals, grievances and provider abrasion.",
"rateOfChange": "KFF, CAQH, CMS API rules and insurance AI governance are making denial, appeal, electronic-adoption and review evidence harder to treat as internal-only.",
"from": "claims, call-centre and UM automation approved separately",
"toward": "agent programmes with appeal outcomes, qualified review and provider-friction telemetry"
},
"watch": [
"15 June 2026: CMS drug prior-authorization proposal comment period closes; pharmacy-benefit payer-agent scope could change [E3]."
],
"gapAnalysis": "Longitudinal payer-agent telemetry linking claim accuracy, denial reversals, appeal timeliness, care-management outcomes, fraud false positives, grievance rates, delayed-care signals, equity slices, provider abrasion and member impact."
},
"body": {
"sections": [
{
"id": "executive-summary",
"title": "Executive summary",
"access": "sample",
"claimIds": [
"C1",
"C2"
],
"evidenceIds": [
"E12",
"E1",
"E14",
"E15",
"E11"
],
"blocks": [
{
"id": "executive-summary-narrative",
"evidenceIds": [
"E12",
"E1",
"E14",
"E15",
"E11"
],
"type": "section_narrative",
"lead": "Payer AI agents need an adverse-member-impact ledger: proof that each AI-touched coverage action lowers operating cost against denial, appeal, overturn, delayed-care, grievance, equity and provider-abrasion denominators.",
"body": [
"Health insurers should anchor AI agents around an adverse-member-impact ledger. The ledger ties each AI-touched benefit answer, authorization, claims edit, fraud hold or care-management outreach to the affected member, plan rule, policy source, reviewer action, appeal or grievance path and downstream outcome.",
"Public denominators now make the ledger concrete. KFF reports 52.8 million Medicare Advantage prior-authorization determinations in 2024, 4.1 million denials, an 11.5% appeal share and an 80.7% overturn share among appealed denials [E12]. A payer agent that cannot export denial, appeal and overturn fields by route is not ready for high-risk coverage work.",
"The API route is wider than PAS submission. CMS interoperability rules make status and data-exchange flows more inspectable [E1], while CRD and DTR evidence shifts diligence toward requirement discovery and documentation collection before a request reaches review [E16, E17]. CAQH's electronic-adoption benchmarks then separate channel readiness from genuine member-impact improvement [E14, E15].",
"Savings evidence should stay lane-specific: electronic authorization can reduce reviewer-minute burden [E15], while individualized review and appeal preservation remain coverage controls [E11]. The broader savings case should be accepted only when private evals show cleaner approvals, fresher policy, fewer repeat contacts and no rise in reversals or grievances. Insurer AI governance and protected-variable mitigation then become contract controls, not afterthoughts [E10, E18]."
],
"detail": [
"Make the ledger a product requirement: member context, plan and product, benefit or policy version, AI output, human reviewer, override, denial reason, appeal or grievance link and outcome monitoring.",
"Treat departmental ROI as incomplete until net-member-impact evidence is supplied. A claims or service gain that raises appeals, complaints or provider abrasion has moved cost rather than removed it."
]
},
{
"id": "board-decision-table",
"title": "The buying decision",
"evidenceIds": [
"E12",
"E1",
"E14",
"E15",
"E11"
],
"type": "table",
"columns": [
{
"key": "question",
"label": "Question",
"align": "left"
},
{
"key": "answer",
"label": "Answer",
"align": "left"
},
{
"key": "move",
"label": "Action",
"align": "left"
}
],
"rows": [
{
"question": "What is the object of approval?",
"answer": "The adverse-member-impact ledger across utilization management, claims, fraud, care management and service.",
"move": "Make denial, appeal, overturn, reviewer, protected-variable and exportable audit fields contract deliverables before production expansion."
},
{
"question": "Which agent goes first?",
"answer": "Low-adverse-impact work with observable outcomes: benefit retrieval, clean-claim exceptions, authorization status and appeal packet assembly.",
"move": "Expand into coverage recommendations only after reviewer capacity, denial reasons, appeal linkage and equity monitoring are proven."
},
{
"question": "What remains blocked?",
"answer": "Autonomous denial, delay, modification, fraud hold or member instruction without policy source, qualified review, override and appeal or grievance linkage.",
"move": "Treat cost-takeout claims as unpriced liability until member-impact metrics are supplied."
}
]
},
{
"id": "route-definition-callout",
"title": "Route definition",
"evidenceIds": [
"E11",
"E14"
],
"type": "callout",
"tone": "neutral",
"body": "Route means the approved path from work to accepted output: the source set, data boundary, model or vendor channel, tools, reviewer, evidence record and reapproval trigger that make an AI result usable."
}
]
},
{
"id": "what-changed",
"title": "What changed",
"access": "sample",
"dek": "Public evidence is now structured enough to define private approval tests.",
"claimIds": [
"C1",
"C2"
],
"evidenceIds": [
"E1",
"E12",
"E2",
"E11",
"E14",
"E15"
],
"blocks": [
{
"id": "what-changed-narrative",
"evidenceIds": [
"E1",
"E12",
"E2",
"E11",
"E14",
"E15"
],
"type": "section_narrative",
"lead": "The trigger is the shift from internal payer productivity claims to member-impact evidence: visible authorization metrics, denial reasons, API traces, qualified review and complaint outcomes.",
"body": [
"Payers determine access to care, move member money, flag providers and create grievances. Agent ROI is credible only when cost takeout is net of denial, appeal and overturn evidence [E12]. Governance, inequity and protected-variable controls need their own evidence trail [E10, E18].",
"Create the member-impact record before scaling automation. Require every high-risk agent to write the policy source, denial or action reason, reviewer action, override, appeal or grievance linkage, equity slice, protected-variable control and outcome metric.",
"For high-risk workflows, the approval record has to connect source evidence, accepted output, reviewer action, exception path, outcome signal and retained audit record before volume or staffing claims matter."
]
},
{
"id": "trigger-table",
"title": "Triggers that change approval timing",
"evidenceIds": [
"E1",
"E12",
"E2",
"E11",
"E14",
"E15"
],
"type": "table",
"columns": [
{
"key": "trigger",
"label": "Trigger",
"align": "left"
},
{
"key": "why_now",
"label": "Why it matters",
"align": "left"
},
{
"key": "buyer_action",
"label": "Decision use",
"align": "left"
}
],
"rows": [
{
"trigger": "Public prior-authorization metrics",
"why_now": "CMS public metrics make prior-authorization operations more visible [E1], while KFF's Medicare Advantage analysis shows denial, appeal and overturn denominators that buyers can mirror privately [E12].",
"buyer_action": "Make each agent return denominator fields by plan, product, request type, member population and appeal outcome."
},
{
"trigger": "2027 API and denial-reason machinery",
"why_now": "FHIR and PAS workflows make request, response, status and denial-reason machinery easier to test against the 2026-2027 CMS milestones [E1, E2]. CRD and DTR add requirement discovery and documentation evidence before submission [E16, E17].",
"buyer_action": "Require requirement discovery, policy version, evidence template, action reason, reviewer action and appeal linkage in the ledger."
},
{
"trigger": "State AI oversight",
"why_now": "AI-supported denial, delay or modification of care faces qualified-review and audit pressure [E6, E11].",
"buyer_action": "Keep adverse coverage actions inspectable, reviewable and linked to grievances or appeals."
},
{
"trigger": "Electronic-adoption gap",
"why_now": "CAQH evidence shows medical prior authorization is still far from fully electronic even as API deadlines approach [E14, E15].",
"buyer_action": "Baseline endpoint success, documentation completeness, fallback channel use and reviewer minutes before accepting savings claims."
}
]
}
]
},
{
"id": "decision-map",
"title": "Decision map",
"access": "sample",
"dek": "Workflow approval changes by authority, source boundary and proof burden.",
"claimIds": [
"C1",
"C2"
],
"evidenceIds": [
"E11",
"E14"
],
"blocks": [
{
"id": "decision-map-narrative",
"evidenceIds": [
"E11",
"E14"
],
"type": "section_narrative",
"lead": "Fund payer agents only where they return concrete denial, appeal, grievance, reviewer, equity and provider-abrasion fields across coverage, claims, fraud, service and care-management work.",
"body": [
"The decision map should start with a member-impact record with member context, plan and product, policy source, AI output, reviewer action, denial or action reason, appeal or grievance link and outcome monitoring: what source record is read, what output is drafted, who approves it, where it is stored and what event forces reapproval.",
"A system can pass a low-risk support test and still fail production work: source evidence, accepted output, integration state, exception handling, reviewer burden and downstream rework have to hold together.",
"The useful vendor question is whether the system can make the named task inspectable, reversible and measurable inside the operating record."
]
},
{
"id": "route-selection-table",
"title": "Workflow selection",
"evidenceIds": [
"E11",
"E14"
],
"type": "table",
"columns": [
{
"key": "route",
"label": "Workflow",
"align": "left"
},
{
"key": "accepted_output",
"label": "Accepted work",
"align": "left"
},
{
"key": "gate",
"label": "Approval gate",
"align": "left"
},
{
"key": "buyer_rule",
"label": "Approval rule",
"align": "left"
}
],
"rows": [
{
"route": "Claims intake and adjudication support",
"accepted_output": "Clean claim, exception work item or payment recommendation tied to member and provider impact.",
"gate": "Benefit rule, code logic, payment policy, human override, appeal risk and audit log [E20].",
"buyer_rule": "Measure payment accuracy net of rework, reversals, complaints and provider abrasion."
},
{
"route": "Utilization management",
"accepted_output": "Reviewed coverage recommendation, approval, denial rationale or appeal packet with policy version.",
"gate": "Qualified reviewer, medical policy, member-specific facts, equity check, Section 1557 mitigation and appeal-right preservation [E11, E18].",
"buyer_rule": "Never let the model become the practical final adverse decision maker."
},
{
"route": "Prior-authorization API and documentation exchange",
"accepted_output": "Coverage-requirement discovery, documentation template, submission, status and denial-reason record across CRD, DTR and PAS-style workflows.",
"gate": "Coverage requirement and evidence fields should be tested through CRD and DTR [E16, E17]. Endpoint, exception fallback, attachment handling and status trace need a separate electronic-adoption test [E14].",
"buyer_rule": "Approve by working payer endpoint and documentation loop, not by standards badges alone."
},
{
"route": "Care management",
"accepted_output": "Risk list, outreach plan, care gap task or programme referral.",
"gate": "Member consent, clinical owner, intervention evidence, care coordination and outcome tracking [E19].",
"buyer_rule": "Approve by population, intervention and non-response risk, not broad member scoring."
},
{
"route": "Member service",
"accepted_output": "Resolved benefit question, routed grievance or human-escalated case.",
"gate": "Benefit source, script, disclosure, escalation and call-quality record [E9].",
"buyer_rule": "Track wrong answers, repeat contacts, grievances and delayed-care risk, not only call deflection."
},
{
"route": "Fraud, waste and abuse holds",
"accepted_output": "Investigation queue, payment hold recommendation or provider-pattern alert with member-access effects.",
"gate": "Evidence threshold, medical-review source, investigator review, false-positive tracking and provider-impact controls [E21].",
"buyer_rule": "Count recoveries net of reversals, false positives and provider abrasion."
}
]
},
{
"id": "workflow-authority-matrix",
"title": "Write authority changes the proof burden",
"caption": "Use the matrix to decide what proof is required before each workflow becomes accepted work.",
"evidenceIds": [
"E11",
"E14"
],
"type": "visual_matrix",
"columns": [
"Source path",
"Reviewer gate",
"System action",
"Retest trigger"
],
"rows": [
{
"label": "Claims intake and adjudication support",
"note": "Clean claim, exception work item or payment recommendation tied to member and provider impact.",
"cells": [
{
"label": "Source named",
"detail": "Benefit rule, code logic, payment policy, human override, appeal risk and audit log [E20].",
"tone": "info",
"strength": "medium"
},
{
"label": "Human gate",
"detail": "Measure payment accuracy net of rework, reversals, complaints and provider abrasion.",
"tone": "blocked",
"strength": "gate"
},
{
"label": "Accepted work",
"detail": "Clean claim, exception work item or payment recommendation tied to member and provider impact.",
"tone": "success",
"strength": "high"
},
{
"label": "Reapproval",
"detail": "Retest when policy, workflow, model, data access or system write rights change.",
"tone": "warning",
"strength": "medium"
}
]
},
{
"label": "Utilization management",
"note": "Reviewed coverage recommendation, approval, denial rationale or appeal packet with policy version.",
"cells": [
{
"label": "Source named",
"detail": "Qualified reviewer, medical policy, member-specific facts, equity check, Section 1557 mitigation and appeal-right preservation [E11, E18].",
"tone": "info",
"strength": "medium"
},
{
"label": "Human gate",
"detail": "Never let the model become the practical final adverse decision maker.",
"tone": "blocked",
"strength": "gate"
},
{
"label": "Accepted work",
"detail": "Reviewed coverage recommendation, approval, denial rationale or appeal packet with policy version.",
"tone": "success",
"strength": "high"
},
{
"label": "Reapproval",
"detail": "Retest when policy, workflow, model, data access or system write rights change.",
"tone": "warning",
"strength": "medium"
}
]
},
{
"label": "Prior-authorization API and documentation exchange",
"note": "Coverage-requirement discovery, documentation template, submission, status and denial-reason record across CRD, DTR and PAS-style workflows.",
"cells": [
{
"label": "Source named",
"detail": "Coverage requirement and evidence fields should be tested through CRD and DTR [E16, E17]. Endpoint, exception fallback, attachment handling and status trace need a separate electronic-adoption test [E14].",
"tone": "info",
"strength": "medium"
},
{
"label": "Human gate",
"detail": "Approve by working payer endpoint and documentation loop, not by standards badges alone.",
"tone": "blocked",
"strength": "gate"
},
{
"label": "Accepted work",
"detail": "Coverage-requirement discovery, documentation template, submission, status and denial-reason record across CRD, DTR and PAS-style workflows.",
"tone": "success",
"strength": "high"
},
{
"label": "Reapproval",
"detail": "Retest when policy, workflow, model, data access or system write rights change.",
"tone": "warning",
"strength": "medium"
}
]
},
{
"label": "Care management",
"note": "Risk list, outreach plan, care gap task or programme referral.",
"cells": [
{
"label": "Source named",
"detail": "Member consent, clinical owner, intervention evidence, care coordination and outcome tracking [E19].",
"tone": "info",
"strength": "medium"
},
{
"label": "Human gate",
"detail": "Approve by population, intervention and non-response risk, not broad member scoring.",
"tone": "blocked",
"strength": "gate"
},
{
"label": "Accepted work",
"detail": "Risk list, outreach plan, care gap task or programme referral.",
"tone": "success",
"strength": "high"
},
{
"label": "Reapproval",
"detail": "Retest when policy, workflow, model, data access or system write rights change.",
"tone": "warning",
"strength": "medium"
}
]
},
{
"label": "Member service",
"note": "Resolved benefit question, routed grievance or human-escalated case.",
"cells": [
{
"label": "Source named",
"detail": "Benefit source, script, disclosure, escalation and call-quality record [E9].",
"tone": "info",
"strength": "medium"
},
{
"label": "Human gate",
"detail": "Track wrong answers, repeat contacts, grievances and delayed-care risk, not only call deflection.",
"tone": "blocked",
"strength": "gate"
},
{
"label": "Accepted work",
"detail": "Resolved benefit question, routed grievance or human-escalated case.",
"tone": "success",
"strength": "high"
},
{
"label": "Reapproval",
"detail": "Retest when policy, workflow, model, data access or system write rights change.",
"tone": "warning",
"strength": "medium"
}
]
}
],
"legend": [
{
"label": "Private eval can start here",
"tone": "success",
"strength": "high"
},
{
"label": "Requires named owner or reviewer",
"tone": "warning",
"strength": "medium"
},
{
"label": "Hard approval gate before scale",
"tone": "blocked",
"strength": "gate"
}
]
}
]
},
{
"id": "signature-proof",
"title": "Signature proof",
"access": "locked",
"dek": "The decisive proof is whether the workflow survives evidence, audit and rework.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "signature-proof-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "provider-workflow-landscape",
"title": "Provider lanes",
"access": "locked",
"dek": "Providers should be compared by workflow authority.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "provider-workflow-landscape-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "use-case-route-selection",
"title": "Workflow selection",
"access": "locked",
"dek": "Production starts with the lane where output can be accepted or rejected visibly.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "use-case-route-selection-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "evidence-and-benchmarks",
"title": "Evidence fit",
"access": "locked",
"dek": "Public evidence maps to local accepted work.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "evidence-and-benchmarks-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "private-eval-design",
"title": "Private eval design",
"access": "locked",
"dek": "Public evidence chooses the tests; local cases decide production.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "private-eval-design-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "risks-and-controls",
"title": "Risks and controls",
"access": "locked",
"dek": "The main risk is ungoverned action.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "risks-and-controls-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "operating-model",
"title": "Operating model",
"access": "locked",
"dek": "Production ownership crosses clinical, technical, compliance and finance teams.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "operating-model-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "economics",
"title": "Economics",
"access": "locked",
"dek": "Price the accepted work.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "economics-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "implementation-signals",
"title": "Public claim tests",
"access": "locked",
"dek": "Vendor pages seed diligence; local telemetry supplies operating proof.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "implementation-signals-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "vendor-directory",
"title": "Diligence directory",
"access": "locked",
"dek": "Representative vendors and platform RFI anchors to include in diligence.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "vendor-directory-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "recommended-next-steps",
"title": "Recommended next steps",
"access": "locked",
"dek": "A practical workflow can be approved in phases without pretending the whole market is ready.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "recommended-next-steps-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "known-unknowns",
"title": "Known unknowns",
"access": "locked",
"dek": "These gaps should shape diligence rather than delay all buying.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "known-unknowns-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "source-ledger",
"title": "Source ledger",
"access": "locked",
"dek": "Primary public sources and evidence rows behind the workflow analysis.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "source-ledger-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "glossary",
"title": "Glossary",
"access": "sample",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "glossary-table",
"title": "Terms used in this report",
"caption": "Definitions are reader aids, not separate evidence claims.",
"evidenceIds": [],
"type": "table",
"columns": [
{
"key": "term",
"label": "Term",
"align": "left"
},
{
"key": "meaning",
"label": "Plain meaning",
"align": "left"
}
],
"rows": [
{
"term": "Route",
"meaning": "The approved path from work to accepted output: source set, data boundary, model or vendor channel, tools, reviewer, evidence record and reapproval trigger."
},
{
"term": "API",
"meaning": "Application programming interface: a governed software connection used by an app or workflow to call a model or service."
}
]
}
]
}
]
}
},
"gap_analysis": "Longitudinal payer-agent telemetry linking claim accuracy, denial reversals, appeal timeliness, care-management outcomes, fraud false positives, grievance rates, delayed-care signals, equity slices, provider abrasion and member impact.",
"kinetics": {
"speed": "moderate",
"impact": 0.92,
"momentum": 0.81,
"businessImpact": "Payer AI depends on net member impact, because administrative savings can reappear as denials, appeals, grievances and provider abrasion.",
"rateOfChange": "KFF, CAQH, CMS API rules and insurance AI governance are making denial, appeal, electronic-adoption and review evidence harder to treat as internal-only.",
"from": "claims, call-centre and UM automation approved separately",
"toward": "agent programmes with appeal outcomes, qualified review and provider-friction telemetry"
},
"watch_signals": [
"15 June 2026: CMS drug prior-authorization proposal comment period closes; pharmacy-benefit payer-agent scope could change [E3]."
],
"sample_findings": [
"The decisive payer AI metric is net adverse member impact: each AI-touched coverage action should tie to denial, delay, grievance, appeal, overturn, equity and provider-abrasion outcomes."
]
}
```